Vaccine Adjuvants Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 1297 | Published Date: Dec 2024 | No. of Page: 107 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL VACCINE ADJUVANTS INDUSTRY
    2.1 Summary about Vaccine Adjuvants Industry
    2.2 Vaccine Adjuvants Market Trends
        2.2.1 Vaccine Adjuvants Production & Consumption Trends
        2.2.2 Vaccine Adjuvants Demand Structure Trends
    2.3 Vaccine Adjuvants Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 Oral
        4.2.2 Subcutaneous
        4.2.3 Intramuscular
        4.2.4 Others
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Veterinary Vaccine Adjuvants
        4.3.2 Human Vaccine Adjuvants
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 Oral
        5.2.2 Subcutaneous
        5.2.3 Intramuscular
        5.2.4 Others
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Veterinary Vaccine Adjuvants
        5.3.2 Human Vaccine Adjuvants
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 Oral
        6.2.2 Subcutaneous
        6.2.3 Intramuscular
        6.2.4 Others
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Veterinary Vaccine Adjuvants
        6.3.2 Human Vaccine Adjuvants
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 Oral
        7.2.2 Subcutaneous
        7.2.3 Intramuscular
        7.2.4 Others
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Veterinary Vaccine Adjuvants
        7.3.2 Human Vaccine Adjuvants
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 Oral
        8.2.2 Subcutaneous
        8.2.3 Intramuscular
        8.2.4 Others
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Veterinary Vaccine Adjuvants
        8.3.2 Human Vaccine Adjuvants
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 Oral
        9.2.2 Subcutaneous
        9.2.3 Intramuscular
        9.2.4 Others
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Veterinary Vaccine Adjuvants
        9.3.2 Human Vaccine Adjuvants
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 SEPPIC
        10.1.2 SDA BIO
        10.1.3 Brenntag Biosector
        10.1.4 SPI Pharma
        10.1.5 MVP Laboratories
        10.1.6 Tj Kaiwei
        10.1.7 Novavax
        10.1.8 Zhuoyue
        10.1.9 Aphios
        10.1.10 GSK
        10.1.11 CSL Limited
        10.1.12 Avanti Polar Lipids
    10.2  Vaccine Adjuvants Sales Date of Major Players (2017-2020e)
        10.2.1 SEPPIC
        10.2.2 SDA BIO
        10.2.3 Brenntag Biosector
        10.2.4 SPI Pharma
        10.2.5 MVP Laboratories
        10.2.6 Tj Kaiwei
        10.2.7 Novavax
        10.2.8 Zhuoyue
        10.2.9 Aphios
        10.2.10 GSK
        10.2.11 CSL Limited
        10.2.12 Avanti Polar Lipids
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
1.Table Vaccine Adjuvants Product Type Overview
2.Table Vaccine Adjuvants Product Type Market Share List
3.Table Vaccine Adjuvants Product Type of Major Players
4.Table Brief Introduction of SEPPIC
5.Table Brief Introduction of SDA BIO
6.Table Brief Introduction of Brenntag Biosector
7.Table Brief Introduction of SPI Pharma
8.Table Brief Introduction of MVP Laboratories
9.Table Brief Introduction of Tj Kaiwei
10.Table Brief Introduction of Novavax
11.Table Brief Introduction of Zhuoyue
12.Table Brief Introduction of Aphios
13.Table Brief Introduction of GSK
14.Table Brief Introduction of CSL Limited
15.Table Brief Introduction of Avanti Polar Lipids
16.Table Products & Services of SEPPIC
17.Table Products & Services of SDA BIO
18.Table Products & Services of Brenntag Biosector
19.Table Products & Services of SPI Pharma
20.Table Products & Services of MVP Laboratories
21.Table Products & Services of Tj Kaiwei
22.Table Products & Services of Novavax
23.Table Products & Services of Zhuoyue
24.Table Products & Services of Aphios
25.Table Products & Services of GSK
26.Table Products & Services of CSL Limited
27.Table Products & Services of Avanti Polar Lipids
28.Table Market Distribution of Major Players
29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
31.Table Global Vaccine Adjuvants Market Forecast (Million USD) by Region 2021f-2026f
32.Table Global Vaccine Adjuvants Market Forecast (Million USD) Share by Region 2021f-2026f
33.Table Global Vaccine Adjuvants Market Forecast (Million USD) by Demand 2021f-2026f
34.Table Global Vaccine Adjuvants Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Vaccine Adjuvants Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Vaccine Adjuvants Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Vaccine Adjuvants Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Vaccine Adjuvants Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Vaccine Adjuvants Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Vaccine Adjuvants Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Vaccine Adjuvants Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Subcutaneous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Intramuscular Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Veterinary Vaccine Adjuvants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Human Vaccine Adjuvants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Subcutaneous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Intramuscular Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Veterinary Vaccine Adjuvants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Human Vaccine Adjuvants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Subcutaneous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Intramuscular Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Veterinary Vaccine Adjuvants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Human Vaccine Adjuvants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Subcutaneous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Intramuscular Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Veterinary Vaccine Adjuvants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Human Vaccine Adjuvants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Subcutaneous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Intramuscular Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Veterinary Vaccine Adjuvants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Human Vaccine Adjuvants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Subcutaneous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Intramuscular Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Veterinary Vaccine Adjuvants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Human Vaccine Adjuvants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Vaccine Adjuvants Sales Revenue (Million USD) of SEPPIC 2017-2020e
72.Figure Vaccine Adjuvants Sales Revenue (Million USD) of SDA BIO 2017-2020e
73.Figure Vaccine Adjuvants Sales Revenue (Million USD) of Brenntag Biosector 2017-2020e
74.Figure Vaccine Adjuvants Sales Revenue (Million USD) of SPI Pharma 2017-2020e
75.Figure Vaccine Adjuvants Sales Revenue (Million USD) of MVP Laboratories 2017-2020e
76.Figure Vaccine Adjuvants Sal
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Vaccine Adjuvants Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Vaccine Adjuvants Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Vaccine Adjuvants Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

UV Sensors Market

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definit ... Read More

UV Lasers Market

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definit ... Read More

UTV Market

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope:  ... Read More